Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TYMS | P04818 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28222624 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL17938394 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL1368110 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL29117516 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL278342 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL16927155 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL34171 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL29188538 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL29188543 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 | |
| Phosphoric Acid SCHEMBL4193412 | 1.00 | CA2 (0.50) | CA2SLC34A1FDPSBLMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115052574-A | Organic and inorganic ingredient synergistic oral compositions for maintaining overall oral health and methods of obtaining and using same | 兔子个人卫生用品工贸有限公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-3152274-A2 | METHODS FOR CONTROLLING SOURING IN ENGINEERED SYSTEMS | The Regents of The University of California (US) | 2017-04-12 | — | — | EP | disclosed |
| EP-1576106-B1 | PROCESS AND MATERIALS FOR PRODUCTION OF GLUCOSAMINE AND N-ACETYLGLUCOSAMINE | ARKION LIFE SCIENCES LLC (US) | 2016-06-22 | — | — | EP | disclosed |
| WO-2015188149-A2 | METHODS FOR CONTROLLING SOURING IN ENGINEERED SYSTEMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-12-10 | — | — | WO | disclosed |
| US-8124381-B2 | Process and materials for production of glucosamine and N-acetylglucosamine | ARKION LIFE SCIENCES (US) | 2012-02-28 | — | — | US | disclosed |
| US-20120009627-A1 | PROCESS AND MATERIALS FOR PRODUCTION OF GLUCOSAMINE AND N-ACETYLGLUCOSAMINE | BIO-TECHNICAL RESOURSES (US) | 2012-01-12 | — | — | US | disclosed |
| EP-1576106-A4 | PROCESS AND MATERIALS FOR PRODUCTION OF GLUCOSAMINE AND N-ACETYLGLUCOSAMINE | ARKION LIFE SCIENCES LLC (US) | 2009-03-18 | — | — | EP | disclosed |
| US-7332304-B2 | Process and materials for production of glucosamine and N-acetylglucosamine | ARKION LIFE SCIENCES LLC (US) | 2008-02-19 | — | — | US | disclosed |
| CN-1250393-C | Surface treated zinc-based metal plated steel sheet | KAWASAKI STEEL CO (JP) | 2006-04-12 | — | — | CN | disclosed |
| EP-1576106-A2 | PROCESS AND MATERIALS FOR PRODUCTION OF GLUCOSAMINE AND N-ACETYLGLUCOSAMINE | Arkion Life Sciences LLC (US) | 2005-09-21 | — | — | EP | disclosed |
| CN-1602190-A | Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis | ESSENTYS AB (SE) | 2005-03-30 | — | — | CN | disclosed |
| US-20040091976-A1 | Process and materials for production of glucosamine and N-acetylglucosamine | ARKION LIFE SCIENCES LLC D/B/A BIO-TECHNICAL RESOURCES DIVISION | 2004-05-13 | — | — | US | disclosed |
| WO-2004003175-A2 | PROCESS AND MATERIALS FOR PRODUCTION OF GLUCOSAMINE AND N-ACETYLGLUCOSAMINE | ARKION LIFE SCIENCES LLC (US) | 2004-01-08 | — | — | WO | disclosed |
| CN-1338988-A | Surface treated zinc-based metal plated steel sheet | KAWASAKI STEEL CO (JP) | 2002-03-06 | — | — | CN | disclosed |